The estimated Net Worth of Kristen Metza is at least $4.48 Миллион dollars as of 1 November 2012. Kristen Metza owns over 30,000 units of Gilead Sciences stock worth over $4,476,387 and over the last 17 years Kristen sold GILD stock worth over $0.
Kristen has made over 15 trades of the Gilead Sciences stock since 2011, according to the Form 4 filled with the SEC. Most recently Kristen exercised 30,000 units of GILD stock worth $1,285,800 on 1 November 2012.
The largest trade Kristen's ever made was exercising 90,000 units of Gilead Sciences stock on 13 September 2012 worth over $3,817,800. On average, Kristen trades about 6,488 units every 15 days since 2007. As of 1 November 2012 Kristen still owns at least 55,305 units of Gilead Sciences stock.
You can see the complete history of Kristen Metza stock trades at the bottom of the page.
Kristen's mailing address filed with the SEC is 333 LAKESIDE DRIVE, , FOSTER CITY, CA, 94404.
Over the last 22 years, insiders at Gilead Sciences have traded over $221,090,692 worth of Gilead Sciences stock and bought 30,121 units worth $1,879,767 . The most active insiders traders include John C Martin, Norbert W Bischofberger и John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of $3,341,365. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth $51,721.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: